Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prevail Therapeutics Inc. | 0 | reported | 22 Jan 2021 | tx 8+67,000−442,749 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jan 2021 | TENDER | Prevail Therapeutics Inc. | 13,000 | — | |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 54,000 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 108,854 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 104,895 | 0.00 USD | deriv |
| 22 Jan 2021 | OTHER | Prevail Therapeutics Inc. | 149,000 | 0.00 USD | deriv |
| 19 Feb 2020 | GRANT_AWARD | Prevail Therapeutics Inc. | 54,000 | 0.00 USD | deriv |
| 24 Dec 2019 | EXERCISE | Prevail Therapeutics Inc. | 13,000 | 0.18 USD | |
| 24 Dec 2019 | EXERCISE | Prevail Therapeutics Inc. | 13,000 | 0.00 USD | deriv |